IVX-A12

· Icosavax, Inc.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for IVX-A12, covering 2025-08-26 to 2025-12-05. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Evaluate the Safety and Immunogenicity of IVX-A12 in Participants of 60 to 85 Years of Age [Phase 2]